These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17146741

  • 1. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
    Foster J, Black J, LeVea C, Khoury T, Kuvshinoff B, Javle M, Gibbs JF.
    Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
    [Abstract] [Full Text] [Related]

  • 2. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW, Chen YX, Wang ZM, Zhou LD, Li XY, Li LX, Luo QZ, Tian W, Fu CY, Zhou JH.
    Hepatogastroenterology; 2008 Feb; 55(82-83):345-50. PubMed ID: 18613363
    [Abstract] [Full Text] [Related]

  • 3. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG.
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
    Buckley AF, Burgart LJ, Kakar S.
    Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP, Xu LW, Su Q, Zhao JH, Li WC, Wang F, Xu Z.
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [Abstract] [Full Text] [Related]

  • 6. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM, Gatalica Z, Lilleberg S, Haynatzki G, Loggie BW.
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [Abstract] [Full Text] [Related]

  • 7. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M.
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor in human hepatocellular carcinoma.
    Hamazaki K, Yunoki Y, Tagashira H, Mimura T, Mori M, Orita K.
    Cancer Detect Prev; 1997 Mar; 21(4):355-60. PubMed ID: 9232327
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M, Saviozzi S, Rapa I, Ceppi P, Cappia S, Calogero R, Novello S, Borasio P, Papotti M, Scagliotti GV.
    Cancer; 2007 Sep 15; 110(6):1321-8. PubMed ID: 17647268
    [Abstract] [Full Text] [Related]

  • 10. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.
    Cortas T, Eisenberg R, Fu P, Kern J, Patrick L, Dowlati A.
    Lung Cancer; 2007 Mar 15; 55(3):349-55. PubMed ID: 17161498
    [Abstract] [Full Text] [Related]

  • 11. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
    Hsu YC, Fu HH, Jeng YM, Lee PH, Yang SD.
    J Clin Oncol; 2006 Aug 10; 24(23):3780-8. PubMed ID: 16754939
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN, Sarioglu S, Birlik B, Sen M, Kinay M.
    Auris Nasus Larynx; 2004 Dec 10; 31(4):417-24. PubMed ID: 15571917
    [Abstract] [Full Text] [Related]

  • 13. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
    Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, Reis H, Cicinnati VR, Schmid KW, Baba HA.
    J Hepatol; 2008 Jan 10; 48(1):83-90. PubMed ID: 17998146
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.
    Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM.
    Cancer; 2003 Feb 15; 97(4):960-8. PubMed ID: 12569594
    [Abstract] [Full Text] [Related]

  • 15. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 15; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 16. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.
    Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kücücük S, Aslay I, Aydiner A, Topuz E.
    Cancer Invest; 2008 Aug 15; 26(7):671-9. PubMed ID: 18608215
    [Abstract] [Full Text] [Related]

  • 17. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

  • 18. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
    Lager DJ, Slagel DD, Palechek PL.
    Mod Pathol; 1994 Jun 15; 7(5):544-8. PubMed ID: 7937720
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor expression and activation in neuroendocrine tumours.
    Shah T, Hochhauser D, Frow R, Quaglia A, Dhillon AP, Caplin ME.
    J Neuroendocrinol; 2006 May 15; 18(5):355-60. PubMed ID: 16629834
    [Abstract] [Full Text] [Related]

  • 20. Expression of epidermal growth factor receptor (EGFR) and activated EGFR predict poor response to (chemo)radiation and survival in cervical cancer.
    Noordhuis MG, Eijsink JJ, Ten Hoor KA, Roossink F, Hollema H, Arts HJ, Pras E, Maduro JH, Reyners AK, de Bock GH, Wisman GB, Schuuring E, van der Zee AG.
    Clin Cancer Res; 2009 Dec 01; 15(23):7389-97. PubMed ID: 19920104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.